HCW Biologics Inc.
HCWB
$1.18
-$0.27-18.62%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 121.32% | -16.71% | 87.38% | 70.58% | 68.42% |
| Total Depreciation and Amortization | -77.01% | 35.44% | 124.71% | 72.07% | 148.54% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1,424.89% | 482.57% | -767.85% | 74.21% | -94.70% |
| Change in Net Operating Assets | 17.08% | -134.70% | -100.45% | -164.02% | -143.60% |
| Cash from Operations | -18.36% | -10.71% | 32.49% | 2.50% | 27.21% |
| Capital Expenditure | -- | -- | -- | -- | 96.95% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 96.95% |
| Total Debt Issued | -100.00% | -100.00% | -92.31% | -- | -- |
| Total Debt Repaid | -5.81% | -6.08% | -6.19% | -9.43% | -5.80% |
| Issuance of Common Stock | -81.26% | -- | -- | -99.93% | 28,190.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 50.92% | -- | -- | -- | -- |
| Cash from Financing | -36.43% | -32.23% | 140.18% | -101.26% | 43,398.04% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -76.73% | -722.87% | 145.55% | -829.45% | 148.21% |